Assignee
SHANDONG ZHONGHAI PHARMACEUTICAL CO LTD
CN·6 granted patents·0 citations·filing 2017–2017
Top patents by PatentIndex Score
6 records- 0153US10993955B2Medicament for use in treating diabetesSHANDONG ZHONGHAI PHARMACEUTICAL CO LTD·Filed 2017·Granted May 4, 2021·0 cites·10 claims
- 0253US10993976B2Medicament for treating uremia and proteinuriaSHANDONG ZHONGHAI PHARMACEUTICAL CO LTD·Filed 2017·Granted May 4, 2021·0 cites·9 claims
- 0353US10772932B2Medicament for use in treating cardiovascular and cerebrovascular diseasesSHANDONG ZHONGHAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·1 claims
- 0453US10772933B2Medicament for treating pulmonary tuberculosisSHANDONG ZHONGHAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·1 claims
- 0552US11000569B2Medicament for use in treating fatty liver, hepatitis and cirrhosisSHANDONG ZHONGHAI PHARMACEUTICAL CO LTD·Filed 2017·Granted May 11, 2021·0 cites·1 claims
- 0644US11364279B2Medicament used for treating hypertensionSHANDONG ZHONGHAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 21, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when SHANDONG ZHONGHAI PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →